SEC Tracker
Get the app

Vaxcyte PCVX

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Vaxcyte files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. PERRIGO PRGO public float $3.7B, Jun 27, 2025
  2. Rhythm Pharmaceuticals RYTM public float $3.8B, Jun 30, 2025
  3. Ultragenyx Pharmaceutical RARE public float $3.4B, Jun 30, 2025
  4. Avidity Biosciences RNAM public float $3.4B, Jun 30, 2025
  5. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025